Molecular mechanisms of chemo‐ and radiotherapy resistance and the potential implications for cancer treatment

231 indexed citations

Abstract

loading...

About

This paper, published in 2021, received 231 indexed citations. Written by Yaping Liu, Can‐Can Zheng, Ming‐Liang He, Wen Xu and Bin Li covering the research area of Oncology and Radiology, Nuclear Medicine and Imaging. It is primarily cited by scholars working on Molecular Biology (126 citations), Oncology (74 citations) and Cancer Research (53 citations). Published in SHILAP Revista de lepidopterología.

In The Last Decade

doi.org/10.1002/mco2.55 →

Countries where authors are citing Molecular mechanisms of chemo‐ and radiotherapy resistance and the potential implications for cancer treatment

Specialization
Citations

This map shows the geographic impact of Molecular mechanisms of chemo‐ and radiotherapy resistance and the potential implications for cancer treatment. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Molecular mechanisms of chemo‐ and radiotherapy resistance and the potential implications for cancer treatment with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Molecular mechanisms of chemo‐ and radiotherapy resistance and the potential implications for cancer treatment more than expected).

Fields of papers citing Molecular mechanisms of chemo‐ and radiotherapy resistance and the potential implications for cancer treatment

Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of Molecular mechanisms of chemo‐ and radiotherapy resistance and the potential implications for cancer treatment. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the Molecular mechanisms of chemo‐ and radiotherapy resistance and the potential implications for cancer treatment.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

This paper is also available at doi.org/10.1002/mco2.55.

Explore hit-papers with similar magnitude of impact

Rankless by CCL
2026